DK1154991T3 - Salicylamid-lanthanidkomplekser til anvendelse som luminescerende markörer - Google Patents

Salicylamid-lanthanidkomplekser til anvendelse som luminescerende markörer

Info

Publication number
DK1154991T3
DK1154991T3 DK00914643T DK00914643T DK1154991T3 DK 1154991 T3 DK1154991 T3 DK 1154991T3 DK 00914643 T DK00914643 T DK 00914643T DK 00914643 T DK00914643 T DK 00914643T DK 1154991 T3 DK1154991 T3 DK 1154991T3
Authority
DK
Denmark
Prior art keywords
salicylamide
lanthanide complexes
ligands
luminescent markers
salicylamidyl
Prior art date
Application number
DK00914643T
Other languages
English (en)
Inventor
Kenneth N Raymond
Stephane Petoud
Seth Cohen
Jide Xu
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of DK1154991T3 publication Critical patent/DK1154991T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10—Non-macromolecular compounds
    • C09K2211/1003—Carbocyclic compounds
    • C09K2211/1007—Non-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/18—Metal complexes
    • C09K2211/182—Metal complexes of the rare earth metals, i.e. Sc, Y or lanthanide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/40—Rare earth chelates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Materials Engineering (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK00914643T 1999-02-18 2000-02-18 Salicylamid-lanthanidkomplekser til anvendelse som luminescerende markörer DK1154991T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12060099P 1999-02-18 1999-02-18
EP00914643A EP1154991B1 (en) 1999-02-18 2000-02-18 Salicylamide-lanthanide complexes for use as luminescent markers
PCT/US2000/004284 WO2000048991A1 (en) 1999-02-18 2000-02-18 Salicylamide-lanthanide complexes for use as luminescent markers
US09/507,599 US6406297B1 (en) 1999-02-18 2000-02-18 Salicylamide-lanthanide complexes for use as luminescent markers

Publications (1)

Publication Number Publication Date
DK1154991T3 true DK1154991T3 (da) 2004-11-22

Family

ID=26818543

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00914643T DK1154991T3 (da) 1999-02-18 2000-02-18 Salicylamid-lanthanidkomplekser til anvendelse som luminescerende markörer

Country Status (9)

Country Link
US (4) US6406297B1 (da)
EP (1) EP1154991B1 (da)
JP (1) JP4943585B2 (da)
AT (1) ATE272049T1 (da)
AU (1) AU762754B2 (da)
CA (1) CA2371818C (da)
DE (1) DE60012485T2 (da)
DK (1) DK1154991T3 (da)
WO (1) WO2000048991A1 (da)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749811B2 (en) 1998-04-28 2004-06-15 The Johns Hopkins University Molecularly imprinted polymer solution anion sensor
JP2002537274A (ja) * 1999-02-17 2002-11-05 ブラッコ インターナショナル ベスローテン フエンノートシャップ 固定化した標識配合物および方法
US6515113B2 (en) * 1999-02-18 2003-02-04 The Regents Of The University Of California Phthalamide lanthanide complexes for use as luminescent markers
AU762754B2 (en) * 1999-02-18 2003-07-03 Regents Of The University Of California, The Salicylamide-lanthanide complexes for use as luminescent markers
DE19936997B4 (de) * 1999-08-02 2007-06-14 Biolitec Ag Verfahren zur Applikation von Photosensibilisatoren (PS) mittels Multiplikatoren in der photodymamischen Therapie
US7897140B2 (en) * 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US20030032675A1 (en) * 2001-02-15 2003-02-13 Franz G. Andrew Manufacture of thyroid hormone tablets having consistent active moiety amounts
US20030224047A1 (en) * 2001-02-15 2003-12-04 Franz G. Andrew Levothyroxine compositions and methods
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
BR0207297A (pt) * 2001-02-15 2005-04-19 King Pharmaceuticals Inc Composição farmacêutica em forma sólida e método de preparar uma forma de dosagem sólida de um ingrediente farmaceuticamente ativo
DE60233574D1 (de) 2001-07-10 2009-10-15 Univ R Verfahren und zusammensetzungen zum nachweis des aktivierungszustands multipler proteine in einzelzellen
US7393656B2 (en) * 2001-07-10 2008-07-01 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for risk stratification
US7381535B2 (en) 2002-07-10 2008-06-03 The Board Of Trustees Of The Leland Stanford Junior Methods and compositions for detecting receptor-ligand interactions in single cells
US20030180353A1 (en) * 2001-08-10 2003-09-25 Franz G. Andrew Stabilized pharmaceutical compositions
US20030198667A1 (en) * 2001-08-10 2003-10-23 Franz Andrew G. Methods of producing dispersible pharmaceutical compositions
US20030198671A1 (en) * 2001-08-10 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique plasma AUC properties
US20030190349A1 (en) * 2001-08-10 2003-10-09 Franz G. Andrew Methods of stabilizing pharmaceutical compositions
US6846915B2 (en) * 2001-08-13 2005-01-25 The Regents Of The University Of California Hydroxypyridonate and hydroxypyrimidinone chelating agents
US20030203967A1 (en) * 2001-08-14 2003-10-30 Franz G. Andrew Levothyroxine compositions having unique Tmax properties
US20030195253A1 (en) * 2001-08-14 2003-10-16 Franz G. Andrew Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
US20030199586A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Unique levothyroxine aqueous materials
US20030199587A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique Cmax properties
US20030198672A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique triidothyronine plasma AUC properties
US20030180356A1 (en) * 2001-10-29 2003-09-25 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Tmax properties
DE60328496D1 (en) 2002-06-27 2009-09-03 Health Research Inc Fluorinierte chlorin und bacteriochlorin photosensitizer für fotodynamische therapie
AU2003249742A1 (en) * 2002-07-02 2004-01-23 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
DK2284266T3 (da) * 2002-11-14 2014-01-13 Thermo Fisher Scient Biosciences Inc sIRNA-MOLEKYLE MOD TP53
US20040161737A1 (en) * 2003-02-14 2004-08-19 Yang Dan-Hui D. Novel luminescent metal chelates and methods for their detection
KR100890885B1 (ko) 2003-03-31 2009-03-31 에프. 호프만-라 로슈 아게 일본 뇌염 바이러스 혈청군의 구성원을 포함하는, 특정플라비바이러스 검출용 조성물 및 방법
EP1641495A4 (en) 2003-05-23 2009-02-25 Epix Pharm Inc OPTICALLY PURE AND ENRICHED ISOMERS OF CHEATING LIGANDS AND CONTRASTANTS
WO2004106907A1 (en) * 2003-05-27 2004-12-09 Alexander Menzel Method for detecting trace explosives using photoluminescence
WO2006001835A2 (en) * 2003-12-30 2006-01-05 The Regents Of The University Of California Aromatic triamide-lanthanide complexes
US7939251B2 (en) 2004-05-06 2011-05-10 Roche Molecular Systems, Inc. SENP1 as a marker for cancer
US20070009980A1 (en) * 2004-06-01 2007-01-11 Applera Corporation Continuous fluorogenic analyte assays with dendritic amplification of signal
CN1707244B (zh) * 2004-06-11 2010-04-07 中国科学院大连化学物理研究所 一种二氧化钛纳米铕荧光探针
JP5243684B2 (ja) * 2004-11-04 2013-07-24 ユー・ディー・シー アイルランド リミテッド 有機金属錯体、発光性固体、有機ｅｌ素子及び有機ｅｌディスプレイ
WO2006055883A2 (en) * 2004-11-19 2006-05-26 The Scripps Research Institute Subnanomolar precipitator of thiophilic metals
US20060275217A1 (en) * 2005-05-06 2006-12-07 Caravan Peter D Chemical exchange saturation transfer contrast agents
US20100291689A1 (en) * 2006-03-21 2010-11-18 Board Of Supervisors Of Louisiana State University & Agricultural And Mechanical College Lanthanide Complexes as Fluorescent Indicators for Neutral Sugars and Cancer Diagnosis
AU2007272604B2 (en) 2006-07-10 2013-08-01 The Regents Of The University Of California Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides
CA2660800C (en) * 2006-08-15 2016-03-01 The Regents Of The University Of California Luminescent macrocyclic lanthanide complexes
EP2114905B1 (en) * 2007-01-25 2015-04-15 Lumiphore, Inc. Multi-color time resolved fluorophores based on macrocyclic lanthanide complexes
EP2179037A4 (en) 2007-08-21 2010-12-22 Nodality Inc DIAGNOSIS, FORECASTING AND TREATMENT PROCEDURES
FR2934684B1 (fr) 2008-07-31 2012-11-16 Cis Bio Int Methode de detection de l'internalisation de proteines membranaires.
US20100151591A1 (en) * 2008-10-31 2010-06-17 Butlin Nathaniel G Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer
US8309306B2 (en) * 2008-11-12 2012-11-13 Nodality, Inc. Detection composition
WO2010075003A1 (en) * 2008-12-16 2010-07-01 The University Of Akron Lanthanide ion complexes and imaging method
US20100233733A1 (en) * 2009-02-10 2010-09-16 Nodality, Inc., A Delaware Corporation Multiple mechanisms for modulation of the pi3 kinase pathway
EP2816038B8 (en) 2009-08-24 2019-12-25 Lumiphore, Inc. Hopo chelators
US9459246B2 (en) 2009-09-08 2016-10-04 Nodality, Inc. Induced intercellular communication
WO2011079291A1 (en) 2009-12-24 2011-06-30 Lumiphore, Inc. Radiopharmaceutical complexes
WO2011155435A1 (ja) 2010-06-07 2011-12-15 コニカミノルタホールディングス株式会社 近接場増強蛍光センサチップ
EP2607888B1 (en) 2010-08-17 2022-01-12 Konica Minolta Holdings, Inc. Spfs sensor equipped with non-specific adsorption type purification mechanism
US20130183696A1 (en) 2010-09-15 2013-07-18 Constance Neely Wilson Methods of use and kit for measurement of lipopolysaccharide with a time resolved fluorescence based assay
DE102011001368B4 (de) * 2011-03-17 2013-01-31 Bundesanstalt für Materialforschung und -Prüfung (BAM) Lanthanoid-Chelate enthaltende Partikel, deren Herstellung sowie deren Verwendung in der Bioanalytik
FR2977674B1 (fr) 2011-07-06 2015-08-14 Cisbio Bioassays Methode amelioree de detection et/ou de quantification d'un analyte present a la surface d'une cellule
EP2738556B1 (en) 2011-07-28 2019-11-06 Konica Minolta, Inc. Method for measuring amount of analyte and device for spfs
CN103890137B (zh) * 2011-08-19 2016-08-24 Dhr芬兰公司 具有三个发色团的发光镧系元素螯合物及其用途
US9944657B2 (en) 2011-08-19 2018-04-17 Radiometer Turku Oy Luminescent lanthanide chelates having three chromophores an their use
FR2980271B1 (fr) 2011-09-16 2013-10-11 Cisbio Bioassays Procede de determination de la glycosylation d'un anticorps
WO2013092992A1 (en) * 2011-12-22 2013-06-27 Dhr Finland Oy Novel luminescent lanthanide chelates with enhanced excitation properties
EP2607884A1 (en) * 2011-12-23 2013-06-26 Essilor International (Compagnie Générale d'Optique) Eyeglass rating with respect to protection against uv hazard
US20150185150A1 (en) 2012-02-22 2015-07-02 Cisbio Bioassays Method for normalizing the luminescence emitted by a measuring medium
FR2988174B1 (fr) 2012-03-19 2014-04-25 Cisbio Bioassays Procede de determination de la capacite d'un anticorps a maintenir des cellules a proximite l'une de l'autre
US9439984B2 (en) 2012-05-31 2016-09-13 The Regents Of The University Of California Macrocycles
CA2891593C (en) 2012-11-16 2021-09-14 Lumiphore, Inc. Di-macrocycles
WO2014147288A1 (en) 2013-01-31 2014-09-25 Kaivogen Oy Luminescent triazacyclononane-based lanthanide chelate complexes as labelling reagents
US11453652B2 (en) 2013-03-15 2022-09-27 Lumiphore, Inc. Di-macrocycles
US9388110B2 (en) * 2013-12-12 2016-07-12 Saudi Arabian Oil Company Liquid phase oxidation of aromatic feedstocks with manganate recycling to produce carboxylic acids
DE102014203266B4 (de) 2014-02-24 2018-07-19 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Zusammensetzung mit FRET-Paar in definierter Geometrie
ES2898633T3 (es) 2014-04-09 2022-03-08 Lumiphore Inc Macrociclos
US10434186B2 (en) 2014-12-22 2019-10-08 Lumiphore, Inc. Functionalized linear ligands and complexes thereof
FR3032797B1 (fr) 2015-02-13 2017-03-03 Cisbio Bioassays Procede de quantification d'une proteine d'interet presente dans un echantillon biologique
US11248269B2 (en) 2015-03-05 2022-02-15 University Of New Hampshire Methods and compositions for identifying pathogenic vibrio parahaemolyticus
JP7523883B2 (ja) 2015-08-13 2024-07-29 ザ ジェネラル ホスピタル コーポレイション 分子ｍｒイメージング用マンガン系キレートコンジュゲート
CN106010502B (zh) * 2015-11-24 2019-03-01 河北科技大学 一种具有氟离子传感性能的稀土介孔杂化发光材料的制备方法
US11614445B2 (en) 2016-06-09 2023-03-28 Radiometer Turku Oy Background blockers for binding assays
CN106317096B (zh) * 2016-08-19 2019-05-28 华南师范大学 一种邻菲罗啉并咪唑型稀土配位分子基探针及其制备方法和应用
AU2017321979B2 (en) 2016-09-02 2022-11-10 Lumiphore, Inc. Macrocyclic ligands with pendant chelating moieties and complexes thereof
EP3568398A1 (en) 2017-01-12 2019-11-20 Société des Produits Nestlé S.A. Cryptate derivatives and their use as luminescent lanthanide complexes
ES2883934T3 (es) * 2017-05-31 2021-12-09 Roche Diagnostics Gmbh Detección por PCR multiplex de fusiones de ALK, RET y ROS
FR3069644B1 (fr) 2017-07-28 2024-07-12 Cisbio Bioassays Methode pour mesurer la modulation de l'activation d'un recepteur couple a une proteine g
WO2019069885A1 (ja) 2017-10-02 2019-04-11 コニカミノルタ株式会社 アナライトの検出方法
JP2021514052A (ja) 2018-02-15 2021-06-03 プロサイズディーエックス インコーポレーテッド アッセイキュベット
EP3752819B1 (en) 2018-02-15 2023-08-09 ProciseDx Inc. Analyzer
EP3762042A4 (en) 2018-03-07 2021-12-22 Lumiphore, Inc. MACROCYCLIC LIGANDS WITH PENDANT CHELATING FRACTIONS AND THEIR COMPLEXES
ES2859775T3 (es) 2018-07-05 2021-10-04 Univ Strasbourg Nanopartículas de lantánido luminiscentes ultrabrillantes que comprenden terbio, con una mayor vida útil de estado excitado
FR3084365B1 (fr) 2018-07-27 2020-10-23 Cisbio Bioassays Anticorps a domaine unique qui se lient a la proteine g alpha
WO2020102556A1 (en) 2018-11-15 2020-05-22 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods of prognosis and classification for preeclampsia
FR3092172B1 (fr) 2019-01-30 2021-02-12 Cisbio Bioassays Méthode pour mesurer la modulation de l’activation d’un récepteur couplé à une protéine G avec des analogues du GTP
JP2022532381A (ja) 2019-05-16 2022-07-14 プロサイセデクス インコーポレイティド Ｖｃａｍ－１及びカルプロテクチンのための分析検出方法
EP3821250B1 (en) 2019-05-16 2022-05-04 ProciseDx Inc. An assay method for the detection of vcam-1 and alpha-2-macroglobulin in blood
EP3973290A1 (en) 2019-05-23 2022-03-30 ProciseDx Inc. Assay methods for the detection of human serum albumin, vitamin d, c-reactive protein, and anti-transglutaminase autoantibody
EP4079752A4 (en) 2019-12-06 2024-03-20 Otsuka Pharmaceutical Co., Ltd. STANDARD SUBSTANCE FOR PSA QUANTIFICATION, PREPARATION METHOD THEREFOR, STANDARD SOLUTION FOR PSA QUANTIFICATION AND PSA QUANTIFICATION METHOD
EP4073066A4 (en) * 2019-12-13 2023-12-27 University of Pittsburgh - of the Commonwealth System of Higher Education LANTHANIDE COMPOUNDS FOR LUMINESCENCE POWER-ON DETECTION
WO2021242725A1 (en) 2020-05-28 2021-12-02 Procisedx Inc. Predetermined calibration curve
EP4343775A1 (en) 2022-09-22 2024-03-27 SurgeCare A method for determining a medical outcome for an individual, related electronic system and computer program

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2588265B3 (fr) * 1985-10-04 1988-01-15 Inst Francais Du Petrole Procede d'adoucissement d'une charge d'hydrocarbures contenant des produits soufres
SE8703682L (sv) * 1987-09-24 1989-03-25 Wallac Oy Homogen bestaemningsmetod som utnyttjar affinitetsreaktioner
WO1992011039A1 (en) 1990-12-17 1992-07-09 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Derivatized tris-catechol chelating agents
DE4222255A1 (de) * 1992-07-07 1994-01-13 Bayer Ag Fotochemische Markierung von Nukleinsäuren mit Europiumchelat-Reagenzien und ihre Verwendung in Gensondentestsystemen
DE19525924A1 (de) 1995-07-04 1997-01-09 Schering Ag Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
DE19728021A1 (de) * 1997-07-01 1999-01-07 Clariant Gmbh Metall-Komplexe als Bleichaktivatoren
AU762754B2 (en) * 1999-02-18 2003-07-03 Regents Of The University Of California, The Salicylamide-lanthanide complexes for use as luminescent markers
US6515113B2 (en) * 1999-02-18 2003-02-04 The Regents Of The University Of California Phthalamide lanthanide complexes for use as luminescent markers

Also Published As

Publication number Publication date
ATE272049T1 (de) 2004-08-15
AU3600600A (en) 2000-09-04
US7018850B2 (en) 2006-03-28
CA2371818A1 (en) 2000-08-24
JP4943585B2 (ja) 2012-05-30
US6406297B1 (en) 2002-06-18
EP1154991B1 (en) 2004-07-28
DE60012485D1 (de) 2004-09-02
US20030027189A1 (en) 2003-02-06
CA2371818C (en) 2009-01-06
WO2000048991A1 (en) 2000-08-24
US20080293155A1 (en) 2008-11-27
DE60012485T2 (de) 2005-08-18
AU762754B2 (en) 2003-07-03
US20060286567A1 (en) 2006-12-21
US7404912B2 (en) 2008-07-29
EP1154991A1 (en) 2001-11-21
JP2003535812A (ja) 2003-12-02

Similar Documents

Publication Publication Date Title
DK1154991T3 (da) Salicylamid-lanthanidkomplekser til anvendelse som luminescerende markörer
DE60016898D1 (de) Phthalamid-lanthanid komplexe zur verwendung als lumineszenzmarker
DE50102815D1 (de) Neue n-phenylpyrrolbisphosphanverbindungen und deren metallkomplexe
ATE407176T1 (de) Aromatische triamid-lanthanid-komplexe
DE69730820D1 (de) Polyazomacrocyclofluoromonoalkylphosphensäure, ihre komplexe zur verwendung als kontrastmittel
ATE248849T1 (de) Verbrückte metallkomplexe
CA2457584A1 (en) Enhancing solubility of iron amino acid chelates and iron proteinates
DE50211846D1 (de) NEUE PHOSPHITVERBINDUNGEN UND DEREN Rh-KOMPLEXE
LV11430A (lv) 2-Piridilmetilenpoliazamakrociklofosfonskabes to kompleksi un atvasinajumi izmantosanai par kontrastvielam
CY1105386T1 (el) Βενζοϋλοσουλφοναμιδια και σουλφονυλβενζαμιδινες για χρηση σαν παραγοντες κατα του ογκου
NO994876D0 (no) Forbundne metallkomplekser for gassfasepolymerisasjoner
DE69514350D1 (de) Gallensäurekonjugate, ihre metallkomplexe und verwandte verwendungen
TR200200068T2 (tr) Nematisital triflüorobütenler
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
AU2001243327A1 (en) Novel quinoline ligands and metal complexes for diagnosis and therapy
ATE228361T1 (de) Reduzierung der kardiotoxizität von antitumormitteln mit manganverbindungen
TR200100075T2 (tr) 2-Kuinolon ihtiva eden farmasötik bileşimler
DE69807558D1 (de) Chelatkomplexe paramagnetischer Metalle mit niedriger Toxizität
DE60009675D1 (de) Protonenpumpinhibitoren enthaltende zusammensetzung
DE60019100D1 (de) Im wesentlichen ölfreie cyclosporin zusammensetzungen
WO2004098524A3 (en) Lipid platinum complexes and methods of use thereof
DK1218385T3 (da) Carbonmonoxidkilde til fremstilling af overgangsmetalcarbonylkomplekser
BR9912037B1 (pt) composições organometálicas.
WO2002040060A3 (en) Conjugates of an antioxidants with metal chelating ligands
HRP20000866B1 (en) A reference compound for use in the analysis of levosimendan batches